Orbimed Advisors LLC, 10% Owner at Passage BIO, Inc. (PASG), sold 349,428 shares at $0.66 ($226K) on 2025-01-10, disclosed to the SEC on 2025-01-14.
Open-market sale of $226k PASG by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.66 | 126,209 | $83K | 36.9% |
| 2 | $0.66 | 126,209 | $83K | 36.9% |
| 3 | $0.64 | 17,986 | $12K | 5.1% |
| 4 | $0.60 | 79,024 | $47K | 21.0% |
| Total | $0.65 avg | 349,428 | $226K | 100% |
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |